Cardiac iPSCs for Drug DiscoveryTuesday, 2 June 2015 at 11:15 Add to Calendar ▼2015-06-02 11:15:002015-06-02 12:15:00Europe/LondonCardiac iPSCs for Drug DiscoveryStem Cells in Drug Discovery 2015 in CambridgeCambridgeSELECTBIOenquiries@selectbiosciences.com Heart disease is the cause of morbidity and mortality in the industrialized world. While the use of human induced pluripotent stem cell (iPSCs) in regenerative medicine is a long-term goal. Recent technological advancement has enabled the generation of patient-specific and disease-specific human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) in vitro. iPSC-CMs carry all the genetic information and therefore may be an ideal platform for elucidating disease modeling, drug screening, and cell therapy. Here I will discuss recent advances in this technology in the cardiovascular field. |